ReviewCureus2025
A Review of Conservative Surgical Approaches for Managing Placenta Accreta Spectrum.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The placenta accreta spectrum (PAS) was previously called the morbidly adherent placenta. It involves a range of pathological adherence of the placenta, including placenta increta, placenta percreta and placenta accreta, depending on the depth of invasion of anchoring villi into the myometrium and beyond. This spectrum of disorder is becoming a frequently encountered problem as a consequence of rising caesarean rates all over the world. Hysterectomy during caesarean delivery (CD) has been the conventional management of PAS. However, associated complications have prompted conservative surgery at the first sitting, with or without interventional radiology. The aim is to reduce blood loss and conserve the uterus if possible. It was decided to review the available literature on this emerging topic. Using PubMed and Google Scholar, our search focused on articles published from 2004 onwards, utilizing search terms "Placenta Accreta Spectrum" OR "Adherent Placenta" and "Caesarean Delivery". The selection for review adhered to specified inclusion/exclusion criteria and finally focused on 50 articles. It was found that published work includes the following conservative approaches: first, to leave the placenta expecting autolysis and resolution; second, to leave the placenta with the intention of a delayed hysterectomy; and third, to resort to an intraoperative arterial occlusion and follow-up. Though the primary objective of reducing blood loss at initial surgery is usually achieved, the success of uterine preservation differs. The availability of a multidisciplinary team for the surgical management of PAS is an important factor to consider. Limiting the extent of surgery at the time of CD, combined with or without arterial embolization/ballooning/ligation, reduces blood loss and limits morbidity with the potential to preserve the uterus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.